期刊文献+

三拗芎葶汤治疗支气管哮喘29例疗效观察 被引量:1

Effectiveness Observation of San'ao Xiongting Decoction on Treating 54 Cases of Bronchial Asthma
下载PDF
导出
摘要 目的:观察中药三拗芎葶汤治疗支气管哮喘急性发作期轻中度发作的有效性。方法:对54例支气管哮喘急性发作期随机分为中药治疗组29例,对照组25例,两组给予常规茶碱缓释片口服,病情严重加服强的松治疗,治疗组给予三拗芎葶汤,对照组给予信必可都保(160ug/4.5ug)吸入Bid,观察两组4周治疗后ACT评分、控显率、肺功能(FEV1/FVC%、PEF)差别。结果:两组ACT评分、控显率差别无统计学意义,两组肺功能(FEV1/FVC%、PEF)差别有统计学意义,治疗组优于对照组。结论:中药三拗芎葶汤治疗支气管哮喘轻中度发作取得一定成效,具有临床应用价值。 Objective: Observing the effects of San'ao Xiongting Decoction on treating acute exacerbation of bronchial asth-ma, the effectiveness of mild to moderate attack. Methods: 54 cases in mild and moderate attack of acute exacerbation asthma, and randomly divided into 2 groups, in which, 29 cases in test group and 25 cases in eontrol group. Two groups received con-ventional Theophylline and oral Prednisone, the test group used San'ao Xiongting Decoction, while the control group used Symbi- cort Turbuhaler 160ug/4. 5ug / suction / Bid. After 4 weeks of treatment, two groups were observed the difference of ACT score, significant control rate, lung function (FEV1/FVC%, PEF). Results: Two groups of ACT score, significant control rate was not statistically significant, but lung function (FEV1/FVC% , PEF) was statistically significance, the treatment group was bet-ter han the control group (P〈0. 05 ). Conclusions: San'ao Xiongting Decoction can achieve certain results to treat bronchial asth-ma of mild to moderate attack, and it has clinical applications.
作者 代平
出处 《四川中医》 2012年第7期78-80,共3页 Journal of Sichuan of Traditional Chinese Medicine
关键词 三拗芎葶汤 支气管哮喘 肺功能 San'ao Xiongting Decoction, Bronchial asthma, Chinese traditional treatment ,Lung function
  • 相关文献

参考文献4

二级参考文献10

共引文献454

同被引文献14

  • 1李锋,刘荣玉.基质金属蛋白酶-9与支气管哮喘[J].国外医学(呼吸系统分册),2004,24(5):343-345. 被引量:15
  • 2卞涛,殷凯生,金淑贤,周锦勇,马秀琴,德伟.T-bet/GATA-3的比值在哮喘大鼠免疫失衡中的意义[J].第四军医大学学报,2006,27(18):1690-1693. 被引量:4
  • 3Haezku A, Macary P, Haddad EB, et al. Expression of Th-2 cytokines interleukin-4 and -5 and Th-1 cytokines interferon- gamma in ovalbumin-exposed sensitized Brown-Norway rats [J]. Immunology, 1996,88 (2) : 247 - 251.
  • 4Ohki Y, Tokuyama K, Mayuzumi H, et al. Characteris- tic features of allergic airway inflammation in a murine model ofinfantile asthma [J]. Int Arch Allergy Immunol, 2005,138(1) :51 - 58.
  • 5Mayuzumi H, Ohki Y, Tokuyama K, et al. Age-related difference in the persistency of allergic airway inflamma- tion and bronchial hyperresponsiveness in a murine model of asthma [J]. Int Arch Allergy Immunol, 2007,143(4): 255 - 262.
  • 6Rifkin IR, Marshak-Rothstein A. T-bet: the Toll-bridge to class-switch recombination? [J]. Nat Immunol, 2003,4(7):650 - 652.
  • 7Olgart Hoglund C, de Blay F, Oster JP, et al. Nerve growth factor levels and localisation in human asthmatic bronchi[J]. Eur Respir J, 2002,20 (5): 1110 - 1116.
  • 8Peeraully MR,Jenkins JR, Trayhurn P. NGF gene ex- pression and secretion in white adipose tissue:regulation in 3T3-L1 adipocytes by hormones and inflammatory cy- tokines[J]. Am J Physiol Endocrinol Metah,2004,287 (2) :331 - 339.
  • 9杜建霖,杨帆,何祝萍,胡勇刚,付伟,连亚娜.三拗芎葶合剂防治支气管哮喘机制探讨[J].现代中西医结合杂志,2008,17(12):1805-1807. 被引量:5
  • 10何会霞,李自红.支气管哮喘实验动物模型的研究进展[J].中国老年学杂志,2008,28(20):2074-2076. 被引量:7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部